مجله تاریخ پزشکی - علمی پژوهشی

Promrat K, Kleiner DE, Niemeier HM. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010; 51(1): 121-129.

Ma J, Hwang SJ, Pedley A, Massaro JM, Hoffmann U, Chung RT, et al. Bi-directional analysis between fatty liver and cardiovascular disease risk factors. Hepatol 2017; 66(2): 777-780.

Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006; 40(1): 1-10.

Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological Association. Hepatology 2012; 55(6): 2005-2023.

Mark D, Arun J, Sanyal MD. Burden of Disease due to Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2020; 49(1): 1-23.

Ghamar Chehreh ME, Vahedi M, Pourhoseingholi MA, Ashtari S, Khedmat H, Amin M, et al. Estimation of Diagnosis and Treatment Costs of Non-Alcoholic Fatty Liver Disease: A Two-Year Observation. Hepatitis Montlity 2013; 13(5): 1-5.

Ashtari S, Pourhoseingholi MA, Zali MR. Non-alcohol fatty liver disease in Asia: Prevention and Planning. World J Hepatol 2015; 7(13): 1788-1796.

Hossain N, Afendy A, Stepanova M, Nader F, Manirath Srishord M, Nila Rafiq N, et al. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009; 7(11): 1224-1229.

Longo D, Fauci A, Kasper D, Hauser S, Jameson J, Loscalzo J. Harrison's Principles of Internal Medicine (Genetic, metabolic and infiltrative diseases affecting the liver chapter). 18th ed. New York: McGraw Hill Professional; 2011.

Newsome PN, Cramb R, Davison SM, Dillon JF, Foulerton M, Godfrey EM, et al. Guidelines on the management of abnormal liver blood tests. Gut 2018; 67(1): 6-19.

Dechun F. The alteration of immune cells in the pathogenesis of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Liver Research 2020; 4(1): 23-27.

Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J Hepatol 2012; 57(1): 157-166.

Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA 2015; 313(22): 2263-2273.

Torres DM, Williams CD, Harrison SA. Features, diagnosis and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012; 10(8): 837-858.

Lotfi A, Saneei P, Hekmatdost A, Salehisahlabadi, A, Shiranian A, Ghiasvand R. The relationship between dietary antioxidant intake and physical activity rate with nonalcoholic fatty liver disease (NAFLD): A case - Control study. Clinical Nutrition ESPEN 2019; 34(1): 45-49.

Avicenna. Al-Qanun dar Tibb. Tehran: Soroosh; 2019. [Persian]

Arzani MA. Mofareh al-Gholoob. Tehran: Almoee; 2013. [Persian]

Rabizadeh F. Introducing Useful Medicinal Plants for Liver Diseases with the Use of Traditional and Classical Refrences. Medical History Journal 2019; 11(39): 45-62. [Persian]

Hakimi F, Jafari P, Mojahedi M, Movahhed M, Tansaz M, Choopani R, et al. The Review of Indices of Liver Temperament (Mizaj) in the Iranian Traditional Medicine (Persian Medicine). Medical History Journal 2019; 11(38): 97-109. [Persian]

Arzani MA. Teb-Akbari. Tehran: Moje Noor; 2014. [Persian]

Aghili Alavi Khorasani Shirazi MH. Mohkazan al-Adviyeh. Tehran: Safir ardehal; 2018. [Persian]

Gilani MK. Hefz al-Sehe Naseri. Tehran: Almoee; 2009. [Persian]

Moradi H, Nojavan F, Pourhoseini M. Historical Course of the Emergence of the Word Su-ul-Qinya (pre-dropsy) in Iranian Traditional Medicine. Medical History Journal 2017; 9(31): 55-62. [Persian]

Shamsi-Baghbanan H, Sharifiyan A, Kamali H, Saghebi R, Ghobanifar Z, Minaei B. Assessment of Phlebotomy in Liver Diseases in Iranian Traditional Medicine. Journal of Islamic and Iranian Traditional Medicine 2013; 3(4): 461-476. [Persian]

Askary F, Siahpoosh MB, Nejatbakhsh F. Principle nutrition for liver in both healthiness and illness: Approach of Allopathic Medicine and Iranian Traditional Medicine. History of Medicine Journal 2014; 19(6): 73-90. [Persian]

Shafiezadeh R, Alavian SM, Namdar H, Gholami Fesharaki M, Poorassar A, Esmaeili Saber SS. The effect of Trachyspermum ammi on functional dyspepsia, severity liver steatosis and liver enzymes in patients with nonalcoholic fatty liver disease: A double blind randomized clinical trial. Journal of Islamic and Iranian Traditional Medicine 2019; 10(3): 209-222. [Persian]

Bullon-Vela V, Abete I, Tur JA, Pinto X, Corbella E, Martinez-Gonzalez MA, et al. Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features. Nutrition 2020; 71(1): 1-8.

Haidari F, Hojhabrimanesh A, Helli B, Seyedian S, Ahmadi-Angali K. An energy-restricted high-protein dietsupplemented with β-cryptoxanthin alleviatedoxidative stress and inflammation in nonalcoholicfatty liver disease: a randomized controlled trial. Nutrition Research 2020; 73(20): 15-26.

Francque SM, Verrijken A, Mertens I, Hubens G, Van Marck E, Pelckmans P, et al. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. Clin Gastroenterol Hepatol 2012; 10(10): 1162-1168.